Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients

Heart and Lung: Journal of Acute and Critical Care

Volumn 44, Issue 3, 2015, Pages 225-229

  Wus, Lisa ^a   Manning, MaryLou ^b   Entwistle, John W C ^c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Driveline dressing change; Driveline infection; Exit site care; Exit site management; Ventricular assist device

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRIVELINE INFECTION; FEMALE; HOSPITAL PATIENT; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WOUND DRESSING; ADVERSE EFFECTS; AGED; BANDAGE; HEART ASSIST DEVICE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS;

ADULT; AGED; BANDAGES; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84929515240     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2015.02.001     Document Type: Article

References (36)

1. Go A.S., Mozaffarian D., Roger V.L., et al. Executive summary: heart disease and stroke statistics: 2013 update: a report from the American Heart Association. Circulation 2013, 127(1):143-146.
2. Khazanie P., Hammill B.G., Patel C.B., et al. Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. JAm Coll Cardiol 2014, 63(14):1395-1404.
3. Mulloy D.P., Bhamidipati C.M., Stone M.L., Ailawadi G., Kron I.L., Kern J.A. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. JThorac Cardiovasc Surg 2013, 145(2):566-574.
4. Spelman D., Esmore D. Ventricular assist device infections. Curr Infect Dis Rep 2012, 14(4):359-366.
5. Barnes K. Complications in patients with ventricular assist devices. Dimens Crit CareNurs 2008, 27(6):233-241. quiz 242-3. 10.1097/01.DCC.0000338867.24293.20.
6. Stewart G.C., Givertz M.M. Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation 2012, 125(10):1304-1315. 10.1161/CIRCULATIONAHA.111.060830.
7. Kirklin J.K., Naftel D.C., Pagani F.D., et al. Sixth INTERMACS annual report: a 10,000-patient database. JHeart Lung Transplant 2014, 33(6):555-564.
8. ® II continuous-flow left ventricular assist system. Expert Rev Med Devices 2011, 8(1):11-21.
9. Goldstein D.J., Naftel D., Holman W., et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. JHeart Lung Transplant 2012, 31(11):1151-1157.
10. Sharma V., Deo S.V., Stulak J.M., et al. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 2012, 94(5):1381-1386.
11. Topkara V.K., Kondareddy S., Malik F., et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010, 90(4):1270-1277.
12. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. JAm Coll Cardiol 2009, 54(4):312-321.
13. Gordon R.J., Weinberg A.D., Pagani F.D., et al. Prospective, multicenter study of ventricular assist device infections. Circulation 2013, 127(6):691-702. 10.1161/CIRCULATIONAHA.112.128132.
14. Bomholt T., Moser C., Sander K., et al. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome. Scand Cardiovasc J 2011, 45(5):273-278.
15. Bond A.E., Bolton B., Nelson K. Nursing education and implications for left ventricular assist device destination therapy. Prog Cardiovasc Nurs 2004, 19(3):85-91.
16. Chinn R., Dembitsky W., Eaton L., et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005, 51(4):461-470.
17. Garatti A., Giuseppe B., Russo C.F., Marco O., Ettore V. Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy. JHeart Lung Transplant 2007, 26(9):956-959.
18. Givertz M.M. Cardiology patient pages: ventricular assist devices: important information for patients and families. Circulation 2011, 124(12):e305-e311. 10.1161/CIRCULATIONAHA.111.018226.
19. Holman W.L., Rayburn B.K., McGiffin D.C., et al. Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg 2003, 75(6):S48-S57.
20. Hozayen S.M., Soliman A.M., Eckman P.M. Comparison of two ventricular assist device dressing change protocols. JHeart Lung Transplant 2012, 31(1):108-109.
21. Hravnak M., George E., Kormos R.L. Management of chronic left ventricular assist device percutaneous lead insertion sites. JHeart Lung Transplant 1993, 12(5):856-863.
22. Morales D.L., Catanese K.A., Helman D.N., et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. JThorac Cardiovasc Surg 2000, 119(2):251-259.
23. Pereda D., Conte J.V. Left ventricular assist device driveline infections. Cardiol Clin 2011, 29(4):515-527.
24. Reedy J.E., Ruzevich S.A., Noedel N.R., Vitale L.J., Merkle E.J. Nursing care of the ambulatory patient with a mechanical assist device. JHeart Transplant 1990, 9(2):97-105.
25. Shoham S., Miller L.W. Cardiac assist device infections. Curr Infect Dis Rep 2009, 11(4):268-273.
26. Wilson S.R., Givertz M.M., Stewart G.C., Mudge G.H. Ventricular assist devices the challenges of outpatient management. JAm Coll Cardiol 2009, 54(18):1647-1659.
27. Zierer A., Melby S.J., Voeller R.K., et al. Late-onset driveline infections: the achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007, 84(2):515-520.
28. Cannon A., Elliott T., Ballew C., et al. Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States. Prog Transplant 2012, 22(4):351-359.
29. Appendix A - Adverse Event Definitions Interagency Registry for Mechanically Assisted Circulatory Support, Accessed 01.07.14. http://www.uab.edu/medicine/intermacs/protocol-3-archive/appendices/appendix-a.
30. Center for Disease Control Surgical site infection (SSI) event Accessed 08.01.15. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf?agree=yes%26next=Accept.
31. Tsiouris A., Paone G., Nemeh H.W., Brewer R.J., Morgan J.A. Factors determining post-operative readmissions after left ventricular assist device implantation. JHeart Lung Transplant 2014, 33:1041-1047.
32. National Institutes of Health Calculate your body mass index Accessed 30.04.14. http://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm.
33. Koval C.E., Thuita L., Moazami N., Blackstone E. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients. JHeart Lung Transplant 2014, 33:1164-1172.
34. Bentz B., Hupcey J.E., Polomano R.C., Boehmer J.P. Aretrospective study of left ventricular assist device-related infections. JCardiovasc Manag 2004, 15(1):9-16.
35. Holman W.L., Pamboukian S.V., McGiffin D.C., Tallaj J.A., Cadeiras M., Kirklin J.K. Device related infections: are we making progress?. JCard Surg 2010, 25(4):478-483.
36. Thoratec HeartMate II LVAS - P060040/S00 Food and Drug Administration, Accessed 01.07.14. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm201473.htm.